The LP-BM5 murine retrovirus elicits murine AIDS (MAIDS) (3,32,36,37,42,(46)(47)(48) characterized by an early dysregulated activation of the immune system and an ensuing profound AIDS. Some important features of MAIDS resemble those of human immunodeficiency virus (HIV)/AIDS in humans, including (i) early-onset hypergammaglobulinemia (hyper-Ig); (ii) splenomegaly and lymphadenopathy; (iii) dependence on CD4 T cells for initiation of disease; (iv) loss of CD4 T-cell function and subsequent severely depressed T-and Bcell responses; (v) increased susceptibility to progressive infection and mortality when exposed to normally nonpathogenic microorganisms; and (vi) the development of immunodeficiencyassociated "opportunistic" neoplasms, including end stage B-cell lymphomas (15, 35). While there are also some significant differences between AIDS and MAIDS, the LP-BM5 retroviral system has been widely used as a mouse model for human AIDS (3,32,36,42,[46][47][48].Pathogenic CD4 T effector cells are required for the initiation and progression of MAIDS, and protective CD8 T effector cells are required for MAIDS resistance (28,44,45,54,55,58). CD8 cytolytic T lymphocytes (CTLs) play a critical role in elimination of virus-infected cells and disease control in several retroviral infections, including murine AIDS (in resistant strains) and human HIV-1 infection. Our laboratory has defined the cellular and molecular bases of CD8 CTL-mediated protection in MAIDS-resistant mouse strains (e.g., BALB/c) (28,44,45,54,55,58), as well as insights into the requirement for CD4 T effector cell-mediated initiation/progression of viral pathogenesis in the prototypic MAIDS-susceptible strain, C57BL/6 (B6) (18-23, 39, 40). Thus, interactions between B and CD4 T cells, mediated via the ligation of CD40 and CD40L (CD154), respectively, are essential for LP-BM5-dependent pathogenesis of MAIDS, both for disease induction and for early progression (20)(21)(22). Lack of LP-BM5-induced pathogenesis can be reversed by reconstituting T-cell-lacking B6.nude or B6.TCR␣ Ϫ/Ϫ mice with CD154 ϩ CD4, but not CD154 Ϫ/Ϫ CD4 or wild-type (wt) CD8, T cells (20-22, 39, 40, 67).Using CD40-cytoplasmic-tail TRAF binding site mutant, transgenic, and knockout mice (18) and a panel of CD4 T-cell receptor (TCR) transgenic mice (39), we have gained further insight into the role these pathogenic CD4 Th cells play in mediating LP-BM5 retroviral pathogenesis. However, the question of their possible epitope specificity versus their polyclonal activation consequent to LP-BM5 infection, which is well described (39), remains unclear.In contrast, while a strong protective CD8 T-cell response occurs in MAIDS-resistant strains, such as BALB/c, the lack of comparable LP-BM5-specific CD8 CTLs appears to be crucial to the development of MAIDS in susceptible mouse strains